1. Recent Advances in the Emerging Therapeutic Strategies for Diabetic Kidney Diseases
   Wei Huang et al, 2022, International Journal of Molecular Sciences CrossRef
2. Apelin-13: A Protective Role in Vascular Diseases
   Guang-Gui Zeng et al, 2024, Current Problems in Cardiology CrossRef
3. Beneficial effects of Apelin-13 on metabolic diseases and exercise
   Ruiming Wen et al, 2023, Frontiers in Endocrinology CrossRef
4. Myonectin, irisin, apelin-13 and Elabela hormones levels as biomarkers for type 2 diabetes mellitus : a systematic review
   null null et al, 2024, The Ukrainian Biochemical Journal CrossRef
5. Apelin‑13 reduces high glucose‑induced mitochondrial dysfunction in cochlear hair cells by inhibiting endoplasmic reticulum stress
   Zhiqiang Huo et al, 2024, Experimental and Therapeutic Medicine CrossRef
6. Molecular mechanisms and therapeutic potential of natural flavonoids in diabetic nephropathy: Modulation of intracellular developmental signaling pathways
   Mahaboob Khan Sulaiman, 2024, Current Research in Pharmacology and Drug Discovery CrossRef
7. Apelinergic system in acute kidney injury: Mechanistic insights and therapeutic potential
   Niraj Sunil Patil et al, 2024, Life Sciences CrossRef
8. Exploring the potential roles of apelin, visfatin, and irisin in energy regulation in farm animals: an overview
   Borhan Shokrollahi et al, 2024, Frontiers in Veterinary Science CrossRef
9. Apelin-13 alleviates intrauterine adhesion by inhibiting epithelial–mesenchymal transition of endometrial epithelial cells and promoting angiogenesis
   Qun Zhao et al, 2024, Human Cell CrossRef
10. Nrf2 signaling in diabetic nephropathy, cardiomyopathy and neuropathy: Therapeutic targeting, challenges and future prospective
    Mehrdad Hashemi et al, 2023, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
11. Effects of conditioned media derived from human Wharton’s jelly mesenchymal stem cells on diabetic nephropathy and hepatopathy via modulating TGF-β and apelin signaling pathways in male rats
    Zeinab Karimi et al, 2024, BMC Endocrine Disorders CrossRef
12. The Role of Apelin–APJ System in Diabetes and Obesity
    Cheng Li et al, 2022, Frontiers in Endocrinology CrossRef
13. Evaluation of Apelin-13 levels in patients with diabetic nephropathy
    Gamze İçen et al, 2022, International Urology and Nephrology CrossRef
14. The effects of apelin-13 against cisplatin-induced nephrotoxicity in rats
    Atilla Topcu et al, 2023, Drug and Chemical Toxicology CrossRef
15. The structural analogue of apelin-12 prevents energy disorders in the heart in experimental type 1 diabetes mellitus
    I.M. Studneva et al, 2024, Biomeditsinskaya Khimiya CrossRef
16. Expression of apelin‑13 and its negative correlation with TGF‑β1 in patients with diabetic kidney disease
    Qi Wang et al, 2024, Experimental and Therapeutic Medicine CrossRef
17. Apelin pathway in cardiovascular, kidney, and metabolic diseases: Therapeutic role of apelin analogs and apelin receptor agonists
    Amanda A. de Oliveira et al, 2022, Peptides CrossRef
18. Taurine Ameliorates Apoptosis via AKT Pathway in the Kidney of Diabetic Rats
    Shuangyue Li et al, 2022, Taurine 12 CrossRef